These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 19688833)

  • 1. Biomarkers in the cerebrospinal fluid and neurodegeneration in Langerhans cell histiocytosis.
    Gavhed D; Akefeldt SO; Osterlundh G; Laurencikas E; Hjorth L; Blennow K; Rosengren L; Henter JI
    Pediatr Blood Cancer; 2009 Dec; 53(7):1264-70. PubMed ID: 19688833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long-term outcome in patients with autoimmune encephalitis.
    Constantinescu R; Krýsl D; Bergquist F; Andrén K; Malmeström C; Asztély F; Axelsson M; Menachem EB; Blennow K; Rosengren L; Zetterberg H
    Eur J Neurol; 2016 Apr; 23(4):796-806. PubMed ID: 26822123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid brain injury biomarkers in children: a multicenter study.
    Shahim P; Darin N; Andreasson U; Blennow K; Jennions E; Lundgren J; Månsson JE; Naess K; Törnhage CJ; Zetterberg H; Mattsson N
    Pediatr Neurol; 2013 Jul; 49(1):31-39.e2. PubMed ID: 23827424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CNS Langerhans cell histiocytosis: Common hematopoietic origin for LCH-associated neurodegeneration and mass lesions.
    McClain KL; Picarsic J; Chakraborty R; Zinn D; Lin H; Abhyankar H; Scull B; Shih A; Lim KPH; Eckstein O; Lubega J; Peters TL; Olea W; Burke T; Ahmed N; Hicks MJ; Tran B; Jones J; Dauser R; Jeng M; Baiocchi R; Schiff D; Goldman S; Heym KM; Wilson H; Carcamo B; Kumar A; Rodriguez-Galindo C; Whipple NS; Campbell P; Murdoch G; Kofler J; Heales S; Malone M; Woltjer R; Quinn JF; Orchard P; Kruer MC; Jaffe R; Manz MG; Lira SA; Parsons DW; Merad M; Man TK; Allen CE
    Cancer; 2018 Jun; 124(12):2607-2620. PubMed ID: 29624648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid biomarkers in patients with neurological symptoms but without neurological diseases.
    Constantinescu R; Mahamud U; Constantinescu C; Eriksson B; Novakova L; Olsson B; Rosengren L; Blennow K; Axelsson M
    Acta Neurol Scand; 2019 Sep; 140(3):177-183. PubMed ID: 31087810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for neurodegeneration in Langerhans cell histiocytosis with neurofilament light in plasma.
    Sveijer M; von Bahr Greenwood T; Jädersten M; Kvedaraite E; Zetterberg H; Blennow K; Lourda M; Gavhed D; Henter JI
    Br J Haematol; 2022 Aug; 198(4):721-728. PubMed ID: 35582775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Searching for neurodegeneration in multiple sclerosis at clinical onset: Diagnostic value of biomarkers.
    Novakova L; Axelsson M; Malmeström C; Imberg H; Elias O; Zetterberg H; Nerman O; Lycke J
    PLoS One; 2018; 13(4):e0194828. PubMed ID: 29614113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurochemical markers of brain damage in cerebrospinal fluid during induction treatment of acute lymphoblastic leukemia in children.
    Osterlundh G; Kjellmer I; Lannering B; Rosengren L; Nilsson UA; Márky I
    Pediatr Blood Cancer; 2008 Apr; 50(4):793-8. PubMed ID: 17973312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychological sequelae in patients with neurodegenerative Langerhans cell histiocytosis.
    Van't Hooft I; Gavhed D; Laurencikas E; Henter JI
    Pediatr Blood Cancer; 2008 Nov; 51(5):669-74. PubMed ID: 18623210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosis.
    Avsar T; Korkmaz D; Tütüncü M; Demirci NO; Saip S; Kamasak M; Siva A; Turanli ET
    Mult Scler; 2012 Aug; 18(8):1081-91. PubMed ID: 22252467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid neurofilament and glial fibrillary acidic protein in patients with cerebral vasculitis.
    Nylén K; Karlsson JE; Blomstrand C; Tarkowski A; Trysberg E; Rosengren LE
    J Neurosci Res; 2002 Mar; 67(6):844-51. PubMed ID: 11891800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteopontin is highly secreted in the cerebrospinal fluid of patient with posterior pituitary involvement in Langerhans cell histiocytosis.
    Li N; Cui L; Ma H; Gong Z; Lian H; Wang C; Zhang Q; Zhao X; Chen X; Tian Y; Yang Y; Wei A; Zhang R; Li Z; Wang T
    Int J Lab Hematol; 2020 Dec; 42(6):788-795. PubMed ID: 32845092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid neurofilament light and tau protein as mortality biomarkers in parkinsonism.
    Constantinescu R; Rosengren L; Eriksson B; Blennow K; Axelsson M
    Acta Neurol Scand; 2019 Aug; 140(2):147-156. PubMed ID: 31070772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High levels of plasma interleukin-17A are associated with severe neurological sequelae in Langerhans cell histiocytosis.
    Ismail MB; Åkefeldt SO; Lourda M; Gavhed D; Aricò M; Henter JI; Delprat C; Valentin H
    Cytokine; 2020 Feb; 126():154877. PubMed ID: 31629106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSF neurofilament proteins levels are elevated in sporadic Creutzfeldt-Jakob disease.
    van Eijk JJ; van Everbroeck B; Abdo WF; Kremer BP; Verbeek MM
    J Alzheimers Dis; 2010; 21(2):569-76. PubMed ID: 20555148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid neurofilament light chain as a biomarker of neurodegeneration in the Tg4510 and MitoPark mouse models.
    Clement A; Mitchelmore C; Andersson DR; Asuni AA
    Neuroscience; 2017 Jun; 354():101-109. PubMed ID: 28461218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An exploratory study of the damage markers NfL, GFAP, and t-Tau, in cerebrospinal fluid and other findings from a patient cohort enriched for suspected autoimmune psychiatric disease.
    Syk M; Tornvind E; Gallwitz M; Fällmar D; Amandusson Å; Rothkegel H; Danfors T; Thulin M; Rasmusson AJ; Cervenka S; Pollak TA; Endres D; van Elst LT; Bodén R; Nilsson BM; Nordmark G; Burman J; Cunningham JL
    Transl Psychiatry; 2024 Jul; 14(1):304. PubMed ID: 39048548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of brain injury biomarkers in acute encephalitis/encephalopathy.
    Tsukahara H; Fujii Y; Matsubara K; Yamada M; Nagaoka Y; Saito Y; Yashiro M; Tsuge M; Goto S; Kitamura T; Hata A; Ichiyama T; Morishima T
    Pediatr Int; 2013 Aug; 55(4):461-4. PubMed ID: 23480596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study.
    Eckerström M; Nilsson S; Zetterberg H; Blennow K; Grahn A
    Sci Rep; 2020 Dec; 10(1):22400. PubMed ID: 33372192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of Selected Biomarkers in Cerebrospinal Fluid During Complex Endovascular Aortic Repair - A Pilot Study.
    Jónsson GG; Marklund N; Blennow K; Zetterberg H; Wanhainen A; Lindström D; Eriksson J; Mani K
    Ann Vasc Surg; 2022 Jan; 78():141-151. PubMed ID: 34175417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.